NP / PA
Askew, Keysha
Askew, Keysha was paid $17K by Medicaid between Sep 2022 and Mar 2023, across 10 billing codes. Its largest line is 99203, doctor's office visit, new patient (routine) — 41% of everything it billed.
33Billing provider infoASKEW, KEYSHA
MT PROSPECT, IL 60056
MT PROSPECT, IL 60056
33aNPI1356945042assigned 11/24/2020
33bProvider typeFamily Nurse Practitioner
28Total paid$17K
24GClaims463
24DCodes billed10
24AFirst – last monthSep 2022 – Mar 2023
Compared with peers
Next to other Family Nurse Practitioner providers in Illinois
Rank by total paid#1,936 of 3,353
Median peer was paid$25K
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 195 | $9K | |
| 2023 | 268 | $8K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 41% | 157 | 151 | $7K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 97 | 95 | $3K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 18% | 39 | 38 | $3K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.0% | 28 | 28 | $1K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 6.8% | 16 | 16 | $1K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2.3% | 16 | 16 | $375.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.4% | 16 | 14 | $223.90 |
| 81003 | <1% | 44 | 43 | $85.26 | |
| 81025 | <1% | 15 | 14 | $68.19 | |
| 99051 | 0% | 35 | 35 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.